Pepto-Bismol pediatric use
Executive Summary
Nov. 23 OTC "feedback" meeting will address issue. Procter & Gamble officials will discuss trial it proposed Sept. 23 to study the product (bismuth subsalicylate) in treating acute diarrhea in children. FDA said it needs more information on the proposed study.